BILLS-110hr3061ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (11)
06:43 Jul 19, 2007
VerDate Aug 31 2005
years
annual
60 days
2007
30 days
JULY 17, 2007
42 U.S.C. 1395w
January 1, 2008
1ST SESSION H. R. 3061
EVENT (1)
the ‘‘Medicare Part D Drug
GPE (4)
Minnesota
the United States of America
Connecticut
Texas
ORG (21)
PDP
RECONSIDERATIONS
the Committee on Energy and Commerce
the Committee on Ways and Means
THE HOUSE OF REPRESENTATIVES
the Federal Register
U.S.C.
Medicare
FDA
SPONSORS.—A
Congress
House of Representa-
MA
1860D–4(b
MULARY
1860D–4(g
SEC
Senate
CHEY
PERSON (12)
AL GREEN
LARSON
ABERCROMBIE
EMANUEL
DAVIS
DOGGETT
MCDERMOTT
STARK
KAPTUR
ALLEN
MCCOLLUM
ENGEL
Topic Classifications
congressional legislation
95.3%
public health
51.5%
government oversight
45.5%
Extracted Keywords
therapeutic
drugs
categories
drug
prescription drug
appeals
utilization
prescription
medicare
drug plan
determinations
medicare prescription
specified
permitted
guidance
Forensic Analysis
PDF Metadata
- Creator
- ACOMP.exe WinVer 1c15 Aug 31 2005
- ModDate
- D:20230110183039Z
- Producer
- Acrobat Distiller 4.0 for Windows; modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20070719203920Z
Sentiment
Polarity
Neutral
0.040
Subjectivity
44%
Objective
No crisis correlations found for this document.
The ML pipeline may still be processing.